Macro context
No recent macro brief.
A paper-trading practice in the tradition of weekly Sunday charts.
Why we're in each position right now, and what we expect to happen next.
No recent macro brief.
Stage 2: close $292.75 > MA150 $265.64 (+10.2%), MA rising, 0.7% off 52w high, vol 0.05× avg
Stage 4: close $62.53 < MA150 $76.49 (-18.2%), MA falling, 30.3% off 52w high, vol 0.04× avg
Stage 2: close $292.75 > MA150 $265.64 (+10.2%), MA rising, 0.7% off 52w high, vol 0.05× avg
Stage 4: close $85.43 < MA150 $97.34 (-12.2%), MA falling, 36.3% off 52w high, vol 0.12× avg
Stage 4: close $598.71 < MA150 $649.49 (-7.8%), MA falling, 24.8% off 52w high, vol 0.06× avg
Stage 4: close $412.62 < MA150 $449.24 (-8.2%), MA falling, 25.7% off 52w high, vol 0.04× avg
Stage 2: close $268.98 > MA150 $229.41 (+17.2%), MA rising, 3.4% off 52w high, vol 0.06× avg
Stage 4: close $412.62 < MA150 $449.24 (-8.2%), MA falling, 25.7% off 52w high, vol 0.04× avg
Intraday momentum continuation. Stock was up +2.23% on the session when we entered long. Claude estimated the move continues into the close with probability 62%. Sized at 2% of NAV.CSCO is up ~2.23% ahead of Q3 earnings, with a headline explicitly flagging the stock as a buy candidate before earnings — suggesting the move is driven by pre-earnings positioning and sector momentum in networking. The broader market is also risk-on today (equities rising, Trump-Xi summit optimism) which provides a macro tailwind. With 390 minutes remaining (essentially a full trading day session ahead), there is ample time for continued drift higher as more investors position ahead of the earnings catalyst, though elevated inflation expectations (T5YIE 1.9σ above trend) could cap the upside for rate-sensitive tech names.
Stage 4: close $48.32 < MA150 $70.19 (-31.2%), MA falling, 44.5% off 52w high, vol 0.04× avg
Stage 4: close $48.32 < MA150 $70.19 (-31.2%), MA falling, 44.5% off 52w high, vol 0.04× avg
Stage 4: close $48.09 < MA150 $70.19 (-31.5%), MA falling, 44.7% off 52w high, vol 0.05× avg
Downward 5-day pressure of -7.06% with the close below its 20-day MA ($181.59). Bought an ATM put to ride the breakdown, financed by 1% of NAV. Implied vol locked at 48.2% (20-day realized) for the option's life.
Stage 4: close $85.43 < MA150 $97.34 (-12.2%), MA falling, 36.3% off 52w high, vol 0.12× avg
Stage 2: close $268.98 > MA150 $229.41 (+17.2%), MA rising, 3.4% off 52w high, vol 0.06× avg
Stage 4: close $598.71 < MA150 $649.49 (-7.8%), MA falling, 24.8% off 52w high, vol 0.06× avg
Stage 2: close $219.45 > MA150 $187.25 (+17.2%), MA rising, 1.3% off 52w high, vol 0.06× avg
Stage 2: close $388.60 > MA150 $309.39 (+25.6%), MA rising, 3.3% off 52w high, vol 0.07× avg
Stage 2: close $428.35 > MA150 $352.90 (+21.4%), MA rising, 2.1% off 52w high, vol 0.06× avg
Stage 2: close $219.45 > MA150 $187.25 (+17.2%), MA rising, 1.3% off 52w high, vol 0.06× avg
Stage 2: close $428.35 > MA150 $352.90 (+21.4%), MA rising, 2.1% off 52w high, vol 0.06× avg
Stage 2: close $98.68 > MA150 $78.42 (+25.8%), MA rising, 0.1% off 52w high, vol 0.16× avg
Upward 5-day pressure of +10.57% with the close above its 20-day MA ($204.69). Bought an ATM call to ride the breakout, financed by 1% of NAV. Implied vol locked at 39.3% (20-day realized) for the option's life.
Stage 2: close $98.68 > MA150 $78.42 (+25.8%), MA rising, 0.1% off 52w high, vol 0.16× avg
Classic gold/silver ratio mean reversion. At entry the approximate spot ratio was 56.01, which placed us in the gold side of the trade (we entered above the 50 midpoint). The thesis is that the ratio reverts toward its long-run average; we ride GLD until it crosses the rotation threshold.
Upward 5-day pressure of +5.59% with the close above its 20-day MA ($89.68). Bought an ATM call to ride the breakout, financed by 1% of NAV. Implied vol locked at 28.1% (20-day realized) for the option's life.
Stage 2: close $388.60 > MA150 $309.39 (+25.6%), MA rising, 3.3% off 52w high, vol 0.07× avg
Downward 5-day pressure of -6.21% with the close below its 20-day MA ($93.74). Bought an ATM put to ride the breakdown, financed by 1% of NAV. Implied vol locked at 42.9% (20-day realized) for the option's life.
Upward 5-day pressure of +5.17% with the close above its 20-day MA ($274.81). Bought an ATM call to ride the breakout, financed by 1% of NAV. Implied vol locked at 26.3% (20-day realized) for the option's life.
LLY has moved up 2.54% today with no accompanying news catalysts or earnings events visible in the headlines, making it difficult to attribute the move to a durable fundamental driver. The macro context around elevated inflation expectations (T5YIE at 1.9σ above trend) is more relevant to Gold, Energy, and TIPS sectors, not large-cap pharma, providing no tailwind support. With only 60 minutes remaining until the forced close, there is limited time for meaningful continuation, and without a clear catalyst the move risks fading or consolidating into the close.
There are no recent headlines or clear catalysts explaining the -3.28% decline in CRM today, making it difficult to assess whether this is a fundamental move or noise/sector rotation. The macro context (elevated 5Y inflation expectations) is more relevant to commodity-linked sectors than enterprise software, offering no directional signal for CRM. With only 60 minutes remaining and no identifiable catalyst, the probability of meaningful continuation is limited and the setup does not meet the threshold for a high-conviction trade.
ABBV has moved up 2.84% with no identifiable news catalyst in the headlines, suggesting the move may be driven by sector rotation, options activity, or thin volume rather than a fundamental event. The macro context (elevated 5Y inflation expectations) is not directly supportive of a healthcare/pharma name like ABBV. With only 60 minutes remaining until the forced close, there is limited time for meaningful continuation, and without a clear catalyst, mean reversion or consolidation is equally plausible.
COST has moved up ~2.1% with no identifiable catalyst from recent headlines, suggesting the move may be gap-related or driven by broader market sentiment rather than a specific fundamental driver. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not directly a tailwind for a consumer staples/warehouse retailer like Costco and could even pressure margins. With only 60 minutes remaining until the forced close, there is limited runway for meaningful continuation, and without a clear catalyst the risk of mean reversion or consolidation is elevated.
UNH has moved up 3.12% with no identifiable catalyst from recent headlines, suggesting this may be a gap or thin-volume spike rather than a news-driven continuation move. The macro context (elevated inflation expectations via T5YIE) is not directly supportive of healthcare sector upside. With only 60 minutes remaining until the forced close, there is limited runway even if momentum were present, and mean-reversion risk in a no-news environment is elevated.
AMD is down 4% but the macro news environment is broadly constructive for AI/chip names — Wedbush's positive AI demand commentary and Intel's massive intraday gain suggest sector sentiment is not uniformly negative, creating reversal risk. The drop may reflect a gap or early-session pressure rather than a sustained catalyst specific to AMD, as no AMD-specific negative news appears in the headlines. With only 60 minutes remaining until the forced close, there is limited time for the move to extend meaningfully, and mean-reversion into the close is common in the absence of a clear ticker-specific catalyst.
There are no recent headlines or catalysts explaining the ~3.5% decline in TSLA today, making it difficult to assess whether this is a fundamental move or noise/technical selling. The macro context (elevated 5-year inflation expectations) is not directly bearish for TSLA specifically. With only 60 minutes remaining until the forced close, there is limited time for a meaningful continuation, and without a clear catalyst, mean-reversion or stabilization into the close is equally plausible.
KO has moved up 2.03% with no identifiable news catalyst to explain the move, suggesting this may be a gap or broader market-driven lift rather than a stock-specific driver. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not particularly favorable for a consumer staples/defensive name like KO as it implies rate pressure. With only 60 minutes remaining, there is limited runway for meaningful continuation, and without a clear fundamental catalyst the probability of sustained buying into the close is below threshold.
There are no recent headlines or clear fundamental catalysts to explain the -4.56% move in ORCL today, making it difficult to assess whether selling pressure has a narrative driver that would sustain it into the close. The macro context (elevated 5-year inflation expectations) is not directly bearish for a large-cap tech/software name like Oracle. With only 60 minutes remaining and no identifiable catalyst, the move may reflect morning institutional selling or thin liquidity rather than a sustained trend, suggesting limited additional downside conviction.
There are no recent headlines or clear catalysts to explain the -3.19% move in AVGO today, making it difficult to assess whether this is a sustained selling episode or a gap-down that may partially recover. The macro context (elevated 5Y inflation expectations) is not directly bearish for semiconductor names like AVGO. With only 60 minutes remaining and no identifiable catalyst supporting continuation, the risk/reward for a directional bet is unfavorable.
There are no recent headlines or identifiable catalysts explaining the 2.28% move in NFLX, making it difficult to assess whether this is driven by sustained buying interest or a thin-volume spike. The macro context (elevated 5-year inflation expectations) is not particularly constructive for a growth/technology name like Netflix, as higher real rates tend to pressure high-multiple equities. With only 60 minutes remaining until the forced close, there is limited runway for meaningful continuation even if the setup were more compelling.
There are no recent headlines or clear fundamental catalysts to explain the -3.43% decline in TSLA today, making it difficult to assess whether this is a sustained move or a mean-reversion opportunity. The macro context around elevated inflation expectations (T5YIE at 1.9σ above trend) is not directly negative for TSLA in the short term and does not provide a strong directional signal. With 74 minutes remaining and no identifiable catalyst, the probability of continuation versus reversal is roughly even, warranting an uncertain stance.
There are no recent headlines or identifiable catalysts explaining the ~4.5% decline in ORCL today, making it difficult to assess whether this is a fundamental driver or technical/flow-driven move. The macro context (elevated 5-year inflation expectations) is most relevant to commodities and TIPS, not directly to an enterprise software name like Oracle. With 74 minutes remaining and no clear news catalyst, mean-reversion pressure is plausible, but without understanding the source of the move, conviction in either direction is low.
UNH has moved up 3.01% today but there are no supporting headlines or catalysts visible to explain the move, making it difficult to assess whether this is a fundamental re-rating or a technical/flow-driven spike. The macro context (elevated inflation expectations via T5YIE) is not directly supportive of managed care/healthcare insurers. With 74 minutes remaining, some mean reversion or consolidation is plausible absent a clear catalyst, so a high-confidence continuation call is not warranted.
AMD is down ~4% today, but the macro backdrop from recent headlines is constructive for AI chip demand, with Wedbush reinforcing AI strength across chips and cloud — this could provide buying pressure into the close and limit further downside. The elevated 5-year inflation breakeven (1.9σ above trend) adds some macro uncertainty, but is not a direct chip sector headwind. With 74 minutes remaining, there is meaningful time for a partial recovery, and the lack of a clear company-specific negative catalyst suggests the move may be overdone rather than a sustained directional trend.
LLY is up 2.42% with no identifiable news catalyst driving the move, making it difficult to assess whether momentum will sustain into the close. The macro context around elevated 5-year inflation expectations is not directly relevant to a large-cap pharma name like LLY. With 74 minutes remaining, there is some time for continuation, but absent a clear fundamental catalyst, the move could easily fade or consolidate near current levels.
COST is up ~2% with 74 minutes remaining but there are no recent headlines or identifiable catalysts driving the move, making it difficult to assess whether this reflects fundamental buying or noise. The macro context (elevated 5-year inflation expectations at 1.9σ above trend) is not a direct tailwind for consumer staples/warehouse retail like Costco. Without a clear catalyst and given that a 2% intraday move in a large-cap like COST without news often reverts partially into the close, continuation is uncertain.
There are no recent headlines or identifiable catalysts to explain the 2.31% intraday move in NFLX, making it difficult to assess whether the move is driven by fundamental news or is simply noise/thin-volume drift. The macro context (elevated 5-year inflation expectations) is not a direct tailwind for growth/tech names like NFLX and could even be a mild headwind. With 74 minutes remaining and no clear catalyst supporting continuation, the move has a reasonable chance of mean-reverting or stalling into the close.
ABBV has moved up 3.16% today with no identifiable headline catalyst in the last 24 hours, making it difficult to assess whether this move has fundamental support or is driven by technical flows or sector rotation. The macro context flags elevated inflation expectations (T5YIE at 1.9σ above trend), which is not a clear tailwind for healthcare/pharma names like ABBV. With 74 minutes remaining, there is insufficient catalyst clarity to confidently expect continuation, and large gap-up moves without news often see partial mean reversion into the close.
There are no recent headlines or clear catalysts explaining the -3.05% move in AVGO today, making it difficult to assess whether this is a fundamental shift or a technical/macro-driven dip. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is a broader headwind for growth/tech names like AVGO but is not a direct catalyst. With 74 minutes remaining, there is limited time for further meaningful downside continuation without a fresh catalyst, and mean-reversion pressure is plausible in the absence of news-driven selling.
There are no recent headlines or clear catalysts explaining CRM's ~2.92% decline today, making it difficult to assess whether selling pressure will persist into the close. The macro context (elevated 5-year inflation expectations) is more relevant to commodities and TIPS than to a software name like CRM, providing no directional edge. With 74 minutes remaining and no identifiable news-driven catalyst, the move could reflect broad market noise or sector rotation, and a partial mean-reversion into the close is equally plausible.
AMD is down ~4.71% but the macro headline environment is actually constructive for AI/chip names — Wedbush reinforced AI demand strength and Intel saw a massive move higher, suggesting sector rotation rather than broad chip weakness may be at play. The elevated 5-year inflation expectations (2.62, +1.9σ) are not a direct AMD catalyst and the positive sector backdrop creates meaningful mean-reversion pressure. With 90 minutes remaining and no clear company-specific negative catalyst visible in the headlines, the risk/reward for continuation is roughly balanced, leaning slightly toward recovery rather than further downside.
COST has moved up 2.08% today with no identifiable catalyst from recent headlines, making it difficult to assess whether this is a sustained move or a gap/spike with limited follow-through. The macro context (elevated 5-year inflation expectations) is not a direct tailwind for consumer staples/warehouse retail like Costco. With 90 minutes remaining, there is some time for continuation, but without a clear fundamental driver, mean reversion or consolidation near current levels is equally plausible.
There are no recent headlines or clear catalysts explaining the -3.66% intraday drop in TSLA, making it difficult to assess whether this is a sustained trend or a temporary dip. The macro context (elevated 5-year inflation expectations) is not directly bearish for TSLA and does not provide a strong directional signal. With 90 minutes remaining and no identifiable news driver, the move could mean-revert into the close as buyers step in at a discount, warranting an uncertain stance rather than a continuation bet.
LLY is up 2.41% with no identifiable catalyst from recent headlines to explain or sustain the move, making it difficult to assign directional conviction. The macro context (elevated inflation expectations via T5YIE) is not directly relevant to large-cap pharma and provides no sector tailwind. With 90 minutes remaining and no clear fundamental driver, the move may represent profit-taking risk or a gap-fill scenario rather than a sustained trend into the close.
There are no recent headlines or identifiable catalysts to explain the 2.22% move in NFLX today, making it difficult to assess whether this is a sustained trend or a low-volume intraday spike. The macro context (elevated 5-year inflation expectations) does not particularly favor consumer discretionary/streaming names and provides no directional tailwind. With 90 minutes remaining there is modest time for continuation, but without a clear fundamental driver the probability of sustained upside into the close is not compelling enough to warrant a high-confidence directional bet.
UNH is up 2.15% with no recent headlines to explain the catalyst, making it difficult to assess whether this move is driven by substantive news or is a thin-volume drift. The macro context (elevated 5-year inflation expectations) is not directly relevant to managed healthcare and provides no sector tailwind. With 90 minutes remaining, there is time for continuation but without a clear catalyst, mean reversion into the close is equally plausible, especially given UNH's recent broader volatility.
There are no recent headlines or clear catalysts explaining the ~3.54% decline in AVGO today, making it difficult to determine whether this is a sustained directional move or a gap/spike that may partially reverse. The macro context (elevated 5-year inflation expectations) is not directly bearish for semiconductors like AVGO, offering no strong confirming signal for continuation. With 90 minutes remaining and no identifiable news driver, mean-reversion pressure is plausible, and the risk/reward for a continuation trade is unclear.
There are no recent headlines or clear catalysts explaining the ~4.84% decline in ORCL, which makes it difficult to assess whether this is a fundamental move or noise/thin-volume selling. The macro context around elevated 5-year inflation expectations is more relevant to commodities and TIPS than to large-cap tech/software like ORCL. With 90 minutes remaining and no supporting narrative, mean-reversion is plausible, but without a clear catalyst for either continuation or reversal, the most prudent call is uncertain.
ABBV has moved up ~2.87% with no identifiable news catalyst in the last 24 hours, suggesting the move may be gap-driven or sector-rotation-related rather than fundamentally supported. The macro context (elevated 5-year inflation expectations) is not directly relevant to a large-cap pharma name like ABBV. With 90 minutes remaining and no clear continuation catalyst, mean reversion or consolidation near current levels is equally plausible as further upside.